Citation Impact
Citing Papers
Heart Failure Outcomes in Clinical Trials of Glucose-Lowering Agents in Patients with Diabetes
2016
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
2020
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
2019
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Pharmacotherapy of type 2 diabetes: An update
2017
The Cardiovascular Biology of Glucagon-like Peptide-1
2016
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
2019
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials
2019
The mechanisms of action of metformin
2017 Standout
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials
2016
Acute kidney injury
2019 Standout
Sustained influence of metformin therapy on circulating glucagon‐like peptide‐1 levels in individuals with and without type 2 diabetes
2016
Non-alcoholic fatty liver disease
2021 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
2018
Type 2 diabetes
2017 Standout
Future glucose-lowering drugs for type 2 diabetes
2016
Diabetes Mellitus and Heart Failure
2017
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
2021
The Discovery and Development of Liraglutide and Semaglutide
2019
Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial
2019
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
2016
Effects of Icosapent Ethyl on Total Ischemic Events
2019
Catalytic ozonation for water and wastewater treatment: Recent advances and perspective
2019
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Reactive species in advanced oxidation processes: Formation, identification and reaction mechanism
2020 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Efficacy and safety of glucagon‐like peptide‐1 receptor agonists in type 2 diabetes: A systematic review and mixed‐treatment comparison analysis
2016
Efficient degradation of 2,4-dichlorophenoxyacetic acid by peroxymonosulfate/magnetic copper ferrite nanoparticles/ozone: A novel combination of advanced oxidation processes
2017
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon‐like peptide‐1 receptor agonists: A systematic analysis of published clinical trials
2016
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Activation of persulfate (PS) and peroxymonosulfate (PMS) and application for the degradation of emerging contaminants
2017 Standout
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction
2017
Diabetic Cardiomyopathy
2018 Standout
Diabetic Kidney Disease
2017 Standout
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Effect of inorganic anions on the performance of advanced oxidation processes for degradation of organic contaminants
2021 Standout
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
2019
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
2017
Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial
2016
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Graphitic Carbon Nitride (g-C3N4)-Based Photocatalysts for Artificial Photosynthesis and Environmental Remediation: Are We a Step Closer To Achieving Sustainability?
2016 Standout
Heterojunction Photocatalysts
2017 Standout
High-Index Faceted Ni3S2 Nanosheet Arrays as Highly Active and Ultrastable Electrocatalysts for Water Splitting
2015 Standout
Clinical Update: Cardiovascular Disease in Diabetes Mellitus
2016
Global burden of heart failure: a comprehensive and updated review of epidemiology
2022 Standout
Management of Diabetes Mellitus in Normal Renal Function, Renal Dysfunction and Renal Transplant Recipients, Focusing on Glucagon-Like Peptide-1 Agonist: A Review Based upon Current Evidence
2019
Fe-based catalysts for heterogeneous catalytic ozonation of emerging contaminants in water and wastewater
2016
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Titanium Dioxide Crystals with Tailored Facets
2014
Works of Xiaodan Wei being referenced
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Hydrothermal growth of multi-facet anatase spheres
2011
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015
Role of Mg in mesoporous MgFe2O4 for efficient catalytic ozonation of Acid Orange II
2015